During total follow up, endometrial adenocarcinoma was reported in 53 women randomized to Tamoxifen Orion tamoxifen citrate 30 cases of FIGO Stage IA, 20 were Stage IB, 1 was Stage IC, and 2 were Stage IIIC, and 17 women randomized to placebo 9 cases were FIGO Stage IA, 6 were Stage IB, 1 was Stage IIIC, and 1 was Stage IVB incidence per 1, 000 women years of 2 <a href=http://nolvadex.one/>nolvadex half life</a> In each trial, similar rates of SREs were observed regardless of the dosing schedule

During total follow up, endometrial adenocarcinoma was reported in 53 women randomized to Tamoxifen Orion tamoxifen citrate 30 cases of FIGO Stage IA, 20 were Stage IB, 1 was Stage IC, and 2 were Stage IIIC, and 17 women randomized to placebo 9 cases were FIGO Stage IA, 6 were Stage IB, 1 was Stage IIIC, and 1 was Stage IVB incidence per 1, 000 women years of 2 <a href=http://nolvadex.one/>nolvadex half life</a> In each trial, similar rates of SREs were observed regardless of the dosing schedule